ciramadol: benzylamine analgesics; structure given in fourth source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 44463 |
| CHEMBL ID | 2104132 |
| CHEBI ID | 135016 |
| SCHEMBL ID | 26731 |
| MeSH ID | M0069621 |
| Synonym |
|---|
| ciramadol |
| wy-15705 |
| D03523 |
| 63269-31-8 |
| ciramadol (usan/inn) |
| wy-15,705 |
| CHEBI:135016 |
| 3-[(r)-dimethylamino-[(1r,2r)-2-hydroxycyclohexyl]methyl]phenol |
| ciramadolum |
| 9nq109ow0g , |
| ciramadol [usan:inn] |
| phenol, 3-((dimethylamino)(2-hydroxycyclohexyl)methyl)-, (1r-(1alpha(r*),2alpha))-(-)- |
| (-)-(1r,2r)-2-((r)-alpha-(dimethylamino)-m-hydroxybenzyl)cyclohexanol |
| unii-9nq109ow0g |
| ciramadolum [inn-latin] |
| wy 15705 |
| CHEMBL2104132 |
| ciramadol [mart.] |
| (-)-(1r,2r)-2-((r)-.alpha.-(dimethylamino)-m-hydroxybenzyl)cyclohexanol |
| ciramadol [mi] |
| ciramadol [usan] |
| phenol, 3-((dimethylamino)(2-hydroxycyclohexyl)methyl)-, (1r-(1.alpha.(r*),2.alpha.))-(-)- |
| ciramadol [inn] |
| SCHEMBL26731 |
| Q5121335 |
| DTXSID601018412 |
| HY-136653 |
| CS-0132849 |
| Excerpt | Reference |
|---|---|
| "Oral ciramadol appears to be a safe and highly effective analgesic." | ( Camu, F, 1981) |
| "Ciramadol is a new opioid agonist-antagonist analgesic with low potential for dependency. " | ( McAdams, J; Stambaugh, JE, 1987) |
| Class | Description |
|---|---|
| cyclohexanols | An alcohol in which one or more hydroxy groups are attached to a cyclohexane skeleton. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 33 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 18 (47.37%) | 5.53% |
| Reviews | 1 (2.63%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 19 (50.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Comparison of the analgesic efficacy and safety oral ciramadol, codeine, and placebo in patients with chronic cancer pain. Journal of clinical pharmacology, Volume: 27, Issue: 2 | 1987 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Preliminary pharmacokinetics of intravenous ciramadol in humans. International journal of clinical pharmacology, therapy, and toxicology, Volume: 22, Issue: 6 | 1984 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Comparative evaluation of ciramadol (WY-15.705), morphine and placebo for treatment of postoperative pain. Acta anaesthesiologica Belgica, Volume: 36, Issue: 2 | 1985 |
| Oral ciramadol in the treatment of postoperative pain. Clinical pharmacology and therapeutics, Volume: 38, Issue: 2 | 1985 |
| Hemodynamic and respiratory effects of dezocine, ciramadol, and morphine. Clinical pharmacology and therapeutics, Volume: 38, Issue: 1 | 1985 |
| The metabolic disposition of 14C-ciramadol in humans. Xenobiotica; the fate of foreign compounds in biological systems, Volume: 16, Issue: 4 | 1986 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |